Development Level

Tbio 4 | 10,625
Tchem 1 | 1,890
Tdark 1 | 7,003

IMPC Term

abnormal response to tactile s... 1 | 16
decreased circulating alanine ... 1 | 53
decreased circulating aspartat... 1 | 27
decreased circulating chloride... 1 | 32
decreased circulating triglyce... 1 | 83
decreased lactate dehydrogenas... 1 | 14
increased body weight 1 | 42
increased circulating chloride... 1 | 43

Disease

ovarian cancer 6 | 8,484
Cancer 4 | 2,346
lung cancer 4 | 4,466
glioblastoma 3 | 5,572
lung adenocarcinoma 3 | 2,713
Adenoma 2 | 165
Autistic Disorder 2 | 320
Breast cancer 2 | 3,094
Carcinoma 2 | 2,147
Cardiofaciocutaneous syndrome 2 | 15
Connective tissue cancer 2 | 9
Costello syndrome 2 | 16
Intellectual disability 2 | 573
Multiple myeloma 2 | 1,327
Neurofibromatosis 2 | 37
Noonan Syndrome 2 | 33
astrocytic glioma 2 | 2,241
astrocytoma 2 | 1,493
atypical teratoid / rhabdoid tumor 2 | 4,369
malignant mesothelioma 2 | 3,162
medulloblastoma, large-cell 2 | 6,234
non-small cell lung cancer 2 | 2,798
osteosarcoma 2 | 7,933
pediatric high grade glioma 2 | 2,712
primary pancreatic ductal adenocarcinoma 2 | 1,271
psoriasis 2 | 6,685
sonic hedgehog group medulloblastoma 2 | 1,482
subependymal giant cell astrocytoma 2 | 2,287
Adenocarcinoma in situ 1 | 15
Adenoid Cystic Carcinoma 1 | 99
Animal Mammary Neoplasms 1 | 136
Biliary Cirrhosis, Secondary 1 | 5
Bipolar Disorder 1 | 266
Bladder Neoplasm 1 | 109
Carcinoma, Transitional Cell 1 | 31
Cardio-facio-cutaneous syndrome 1 | 6
Chronic Lymphocytic Leukemia 1 | 242
Costello syndrome (disorder) 1 | 7
DOID:2415 1 | 4
DOID:2627 1 | 14
DOID:9917 1 | 4
Diarrhea 1 | 155
Exanthem 1 | 39
Exophthalmos 1 | 16
Familial adenomatous polyposis 1 | 31
Fibrosarcoma 1 | 12
Ganglioglioma 1 | 16
Glioma 1 | 65
Head and neck squamous cell carcinoma 1 | 12
Hemangioma 1 | 35
Hemangiosarcoma 1 | 18
Hepatocellular Adenoma 1 | 10
Hydrocephalus 1 | 60
Immune system cancer 1 | 38
Intestinal benign neoplasm 1 | 11
Juvenile Myelomonocytic Leukemia 1 | 21
Kidney cancer 1 | 118
LEOPARD Syndrome 1 | 20
Learning disability 1 | 20
Leukemia, Myelocytic, Acute 1 | 113
Liposarcoma 1 | 20
Liver Cirrhosis 1 | 101
Liver Neoplasms, Experimental 1 | 48
Liver carcinoma 1 | 217
Liver neoplasms 1 | 109
Lung Neoplasms 1 | 171
Lynch syndrome 1 | 33
Mammary Neoplasms 1 | 410
Mammary Neoplasms, Experimental 1 | 150
Melanoma 1 | 261
Mouth Neoplasms 1 | 42
Neoplasm Invasiveness 1 | 127
Neoplasms, Experimental 1 | 33
Neoplastic Cell Transformation 1 | 81
Neoplastic Syndromes, Hereditary 1 | 48
Neurilemmoma 1 | 20
Neurofibroma 1 | 9
Neutropenia 1 | 78
Newcastle disease 1 | 13
Pancreatitis 1 | 97
Papillary thyroid carcinoma 1 | 37
Papilloma 1 | 27
Parkinson's disease 1 | 364
Paronychia 1 | 7
Penile Neoplasms 1 | 4
Persistent generalized lymphadenopathy 1 | 15
Phaeochromocytoma 1 | 20
Pheochromocytoma 1 | 22
Plummer's disease 1 | 7
Precancerous Conditions 1 | 69
Sarcoma 1 | 49
Scoliosis 1 | 40
Seminoma 1 | 15
Skin Neoplasms 1 | 49
Squamous cell carcinoma 1 | 94
Substance-Related Disorders 1 | 114
Thyroid Neoplasm 1 | 33
Thyroid cancer 1 | 25
Upper respiratory tract disease 1 | 7
Urinary bladder cancer 1 | 31

Tissue

Blood and immune system 6 | 17,995
Cardiovascular System 6 | 17,958
Digestive Tract 6 | 18,473
Endocrine System 6 | 18,512
Female tissues 6 | 18,647
Liver and Pancreas 6 | 18,136
Male tissues 6 | 17,969
Nervous System 6 | 18,561
Respiratory system 6 | 17,484
Skin and soft tissues 6 | 18,115
Urinary Tract 6 | 18,444

Target Family

Non-IDG 4 | 11,971
Enzyme 2 | 4,146

Grant Application

5R01CA118762-10 6 | 6
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Phorbol-12-myristate-13-acetate-induced protein 1 PMAIP1 Tbio Non-IDG -2.66052 440.9 327
GTPase HRas HRAS Tchem Enzyme -3.97914 9497.9 312
S-phase kinase-associated protein 1 SKP1 Tbio Enzyme -2.55705 305.8 337
Neurofibromin NF1 Tbio Non-IDG -3.55988 3833.1 331
Dynactin subunit 6 DCTN6 Tdark Non-IDG 0.39 0.47 94
RING-box protein 2 RNF7 Tbio Non-IDG -1.33581 21.7 113